Search results for "Prostate Cancer"


 
Results 11 - 20 of about 115 for "Prostate Cancer".
Sort by: Relevance | Newest | Oldest

Oral drug for postpartum depression approved

This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/10/oral-drug-for-postpartum-depression-approved.htm
1 Oct 2023

Little difference found among prostate cancer treatments regarding clinical results, patient-reported outcomes

More men in the active-monitoring group developed metastases than in the surgery or radiotherapy groups, and there were higher rates of disease progression in the active-monitoring group than in the surgery or radiotherapy groups.
https://immattersacp.org/weekly/archives/2016/09/20/2.htm
20 Sep 2016

OTC birth control pill, naloxone gain approval

This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/09/otc-birth-control-pill-naloxone-gain-approval.htm
1 Sep 2023

More patients undergoing active surveillance for lower-risk prostate cancers

Use of active surveillance or watchful waiting for prostate cancer rose from 2010 to 2018, although uptake was lower in men with multiple positive biopsy cores and those who were Asian/Pacific Islander and Hispanic, had a lower income, or lived in a rural area.
https://immattersacp.org/weekly/archives/2023/04/11/4.htm
11 Apr 2023

Sorting through the science of PSA screening

An expert clears up issues surrounding prostate cancer screening recommendations at Internal Medicine Meeting 2022.
https://immattersacp.org/archives/2022/07/sorting-through-the-science-of-psa-screening.htm
1 Jul 2022

Comorbid illnesses still more likely to kill prostate cancer survivors

Veterans Affairs solicits applications for centers of excellence
https://immattersacp.org/weekly/archives/2010/08/31/6.htm
31 Aug 2010

Guidelines suggest more informed consent for prostate cancer screening

MKSAP Quiz: optimal management of coronary artery disease
https://immattersacp.org/weekly/archives/2010/03/09/2.htm
9 Mar 2010

No mortality benefit associated with primary androgen deprivation therapy in localized prostate cancer

Primary androgen deprivation therapy (PADT) yielded no mortality benefit compared with no PADT in men with clinically localized prostate cancer, according to a new study.
https://immattersacp.org/weekly/archives/2014/03/25/5.htm
25 Mar 2014

New guidance urges caution on testosterone

Internists considering testosterone therapy are ideally positioned to consider a broader differential diagnosis that will actually help the patient.
https://immattersacp.org/archives/2020/05/new-guidance-urges-caution-on-testosterone.htm
1 May 2020

European study finds prostate cancer mortality reduced by PSA screening

Prostate-specific antigen (PSA)-based screening significantly reduced mortality from prostate cancer but did not affect all-cause mortality, according to two more years of follow-up results in the European Randomized Study of Screening for Prostate Cancer.
https://immattersacp.org/weekly/archives/2012/03/20/4.htm
20 Mar 2012

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next